Published in Pediatrics on November 01, 1967
Dissociation of intrinsic factor from its antibody: application to study of pernicious anaemia gastric juice specimens. Br Med J (1969) 1.25
Gastric intrinsic factor. Gut (1968) 0.88
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Quantitative studies of immunofluorescent staining. Relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors. Bull World Health Organ (1968) 2.72
Antibodies to type II collagen in relapsing polychondritis. N Engl J Med (1978) 2.65
Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab (2000) 2.34
Immunologic abnormalities induced by postperfusion cytomegalovirus infection. Ann Intern Med (1970) 2.06
Cryoglobulinemia and disease. Ann Intern Med (1970) 2.06
Imaging the expression of transfected genes in vivo. Cancer Res (1995) 2.05
Method for avoiding false-positive results occurring in immunoglobulin M enzyme-linked immunosorbent assays due to presence of both rheumatoid factor and antinuclear antibodies. J Clin Microbiol (1981) 2.03
Impact of clozapine on completed suicide. Am J Psychiatry (2001) 1.93
Some neurophysiological constraints on models of word naming. Neuroimage (2005) 1.88
False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies. Appl Microbiol (1971) 1.85
Modulator binding protein. Bovine brain protein exhibiting the Ca2+-dependent association with the protein modulator of cyclic nucleotide phosphodiesterase. J Biol Chem (1977) 1.79
The occurrence of antibodies to collagen in synovial fluids. Clin Immunol Immunopathol (1975) 1.74
Coexistence of systemic lupus erythematosus and rheumatoid arthritis. Report of a case and review of the literature, with clinical, pathologic and serologic observations. Am J Med (1969) 1.73
Antinuclear factors in synovia. Possible participants in the rheumatoid inclusion body. JAMA (1966) 1.67
In vitro interaction of Bacteroides fragilis with polymorphonuclear leukocytes and serum factors. Infect Immun (1975) 1.67
Pseudo-leukocytosis associated with cryoglobulinemia. Am J Clin Pathol (1973) 1.66
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum (1982) 1.62
Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis (1973) 1.61
Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med (1974) 1.59
Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A (1974) 1.55
Extracellular K(+) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and beta1 integrins. J Exp Med (2000) 1.52
Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology (2001) 1.51
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum (1982) 1.51
Clinical, serologic and leukocyte function studies on patients with idiopathic "acquired" agammaglobulinemia and their families. Am J Med (1970) 1.50
The significance of antinuclear factors in rheumatoid arthritis. Arthritis Rheum (1965) 1.46
synaptotagmin mutants reveal essential functions for the C2B domain in Ca2+-triggered fusion and recycling of synaptic vesicles in vivo. J Neurosci (2001) 1.45
Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide. Arthritis Rheum (1976) 1.44
Effect on lung growth of cervical cord section in the rabbit fetus. Early Hum Dev (1979) 1.44
Selective absence of IgA: a family study. J Lab Clin Med (1968) 1.43
The prevention of asbestos-induced hemolysis. Life Sci (1975) 1.42
Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old. Am J Obstet Gynecol (1995) 1.39
Method for differentiation of nonspecific from specfic toxoplasma IgM fluorescent antibodies in patients with rheumatoid factor. Proc Soc Exp Biol Med (1975) 1.39
Immunofluorescent patterns and specificity of human antinuclear antibodies. Clin Exp Immunol (1968) 1.36
Alveolar development in the human fetus and infant. Early Hum Dev (1986) 1.36
Lobular capillary hemangiomas: An epidemiologic report, with emphasis on cutaneous lesions. J Am Acad Dermatol (2000) 1.32
Purification of the heat-stable inhibitor protein of the Ca2+-activated cyclic nucleotide phosphodiesterase by affinity chromatography. Can J Biochem (1978) 1.29
Naturally occurring human antibodies to the F(ab')2 portion of IgG. Clin Exp Immunol (1980) 1.29
The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev (1987) 1.27
'Nuclear' antigens and antinuclear antibodies in mink sera. Immunology (1969) 1.27
Characterization of pulmonary surfactant from ox, rabbit, rat and sheep. Biochem J (1975) 1.27
Search for infectious agents in rheumatoid arthritis. Arthritis Rheum (1966) 1.27
Treatment of corticosteroid-resistant polymyositis with methotrexate. Lancet (1971) 1.27
Pulmonary fat accumulation after intralipid infusion in the preterm infant. Lancet (1980) 1.27
Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG). Clin Exp Immunol (1979) 1.25
Is fetal respiratory function a major determinant of perinatal survival? Lancet (1982) 1.25
Antinuclear antibodies in rabbit antisera. J Exp Med (1966) 1.24
Purification and subunit structure of bovine brain modulator binding protein. J Biol Chem (1979) 1.24
Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy (1997) 1.24
Altered immunoglobulin metabolism in systemic lupus erythematosus and heumatoid arthritis. J Clin Invest (1970) 1.23
Fetal lung hypoplasia: biochemical and structural variations and their possible significance. Arch Dis Child (1981) 1.23
School eye health appraisal. Indian J Ophthalmol (1990) 1.21
Detection of nuclear antigens (DNA) in normal and pathologic human fluids by quantitative complement fixation. Arthritis Rheum (1968) 1.20
Serologic abnormalities associated with L-dopa therapy. Vox Sang (1971) 1.19
Cutaneous anergy without systemic disease. A syndrome associated with mucocutaneous fungal infection. Am J Med (1968) 1.18
Preventing hypothermia: convective and intravenous fluid warming versus convective warming alone. J Clin Anesth (1998) 1.18
Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann N Y Acad Sci (2000) 1.17
"Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab (1998) 1.15
A modified agarose method for detection of migration inhibitory factor and delineation of its antigen dependency. Int Arch Allergy Appl Immunol (1973) 1.14
Essential cryoglobulinemia. Immunologic studies before and after penicillamine therapy. Arch Intern Med (1970) 1.13
Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis. Clin Exp Immunol (1971) 1.12
Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates. Biochemistry (2007) 1.11
Juvenile rheumatoid arthritis--a serologic survey of 200 consecutive patients. J Pediatr (1970) 1.11
Identification of intrinsic factor autoantibody and intrinsic factor in man by radioimmunodiffusion and radioimmunoelectrophoresis. J Immunol (1965) 1.10
A simplified method for lymphocyte separation. Vox Sang (1972) 1.10
Use of DNA estimation for growth assessment in normal and hypoplastic fetal lungs. Arch Dis Child (1981) 1.10
Refractory megaloblastic anemia with myeloperoxidase-deficient neutrophils. Ann Intern Med (1972) 1.09
Studies of cryoprecipitates from synovial fluid of rheumatoid patients. Immunology (1971) 1.08
Hidden rheumatoid factor in seronegative nodular rheumatoid arthritis. Lancet (1969) 1.07
Evaluation of fluorescent antinuclear antibody assays, Crithidia luciliae substrate, and single-stranded DNA-binding capacity in diagnosis of four rheumatic diseases. J Clin Microbiol (1982) 1.07
Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology (2014) 1.07
Serological heterogeneity of the IgM components of mixed (monoclonal IgM-polyclonal IgG) cryoglobulins. Clin Exp Immunol (1968) 1.06
Auto-antibodies of the IgD class. Clin Exp Immunol (1970) 1.06
Catabolism and synovial transport of rheumatoid factor. Ann Rheum Dis (1970) 1.05
Decreased Fc receptor avidity and degradative function of monocytes from patients with systemic lupus erythematosus. J Immunol (1983) 1.04
Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis. Arthritis Rheum (1974) 1.04
Circulating immune complexes in cystic fibrosis. Pediatr Res (1980) 1.04
Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clin Exp Immunol (1996) 1.03
The adsorption of biological macromolecules by mineral dusts. Environ Res (1978) 1.03
Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy. Arthritis Rheum (1974) 1.03
Characterization of anti-F(ab')2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies. Clin Immunol Immunopathol (1982) 1.02
Cell-mediated immunity to synovial antigens in rheumatoid arthritis. Lancet (1973) 1.02
Antinuclear factors in rheumatoid arthritis. Ann N Y Acad Sci (1965) 1.01
Spontaneous coronary artery dissection in the postpartum period: association with antiphospholipid antibody. Heart (2004) 1.01
Substrate competition between DNase I and anti-DNA antibody. Clin Immunol Immunopathol (1977) 1.01
Mixed gamma G-gamma M cold agglutinin. J Immunol (1967) 1.01
A prospective study of intrapulmonary fat accumulation in the newborn lung following intralipid infusion. Acta Paediatr Scand (1984) 1.01
Lymphocytotoxins and pernicious anemia. Blood (1972) 0.99
Benchmarking treatment of schizophrenia: a comparison of service delivery by the national government and by state and local providers. J Nerv Ment Dis (2000) 0.99
Inhibition of macrophage migration: a test system using human monocytes. J Immunol (1971) 0.99
Chrysotile asbestos: biological reaction potential. Inhaled Part (1975) 0.98